Dixon MRI Imaging Histology for Predicting Postoperative Infection in Posterior Lumbar Fusion for Myasthenia Gravis
1 other identifier
observational
1,300
0 countries
N/A
Brief Summary
Sarcopenia is an age-related condition that manifests itself as a persistent decrease in muscle mass and function, which may lead to decreased physical function, increased risk of disease, and reduced quality of life. In surgical patients, sarcopenia has been shown to be associated with increased postoperative complications, prolonged hospitalization, and decreased survival. In patients undergoing lumbar fusion, the presence of sarcopenia may increase the risk of postoperative infection.Lumbar fusion is a common procedure to treat lumbar spine disorders such as lumbar disc herniation, lumbar spondylolisthesis, or lumbar spinal stenosis. However, this procedure is associated with a high rate of complications, especially postoperative infections, which can lead to reoperation, prolonged hospitalization, and even affect patient survival. In recent years, more and more studies have found a significant association between sarcopenia and postoperative infections after lumbar fusion surgery.Imagingomics belongs to a branch of machine learning, which is the process of acquiring images from various imaging devices such as CT, MRI and ultrasound, outlining the region of interest through image segmentation, extracting the features of the image within the region of interest, downscaling the features, and finally building an imagingomics model. MRI Imagingomics, utilizing its rich data information, has shown great potential for application in several medical fields. Among them, the accuracy of Dixon MRI imaging histology in muscle mass and texture assessment makes it particularly important in predicting postoperative infections.Based on this, it is reasonable to believe that Dixon MRI imaging histology can be a powerful tool to help us predict a patient's risk of postoperative infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 28, 2025
CompletedStudy Start
First participant enrolled
February 1, 2025
CompletedFirst Posted
Study publicly available on registry
February 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2026
CompletedFebruary 3, 2025
January 1, 2025
11 months
January 28, 2025
January 28, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
fat fraction
Two weeks before treatment
Study Arms (2)
postoperative infection
Non-operative infections
Eligibility Criteria
Retrospective multicenter collection of infected/non-infected myasthenia gravis and non-myasthenia gravis patients after posterior lumbar fusion at our institution and at each of the collaborating research institutions.
You may qualify if:
- Male and female patients over 18 years of age.
- The patient underwent posterior lumbar fusion and had a Dixon MRI scan within 2 weeks prior to surgery.
- Patients were able to understand the purpose and procedures of the study and were willing to sign an informed consent form.
- The patient's clinical consultation and follow-up information was complete.
You may not qualify if:
- The patient has contraindications to MRI, such as implanted metal devices (e.g., pacemakers) or severe claustrophobia.
- Patients with serious other medical conditions, such as heart disease, kidney disease or liver disease, which may affect their post-operative recovery.
- Patients have known immune system disorders or are on immunosuppressive therapy, which may affect their risk of infection.
- The patient has had other spinal surgery within the last 6 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- doc
Study Record Dates
First Submitted
January 28, 2025
First Posted
February 3, 2025
Study Start
February 1, 2025
Primary Completion
December 31, 2025
Study Completion
February 28, 2026
Last Updated
February 3, 2025
Record last verified: 2025-01